RC Siniard, R Gangaraju, JE May… - Expert Review of …, 2023 - Taylor & Francis
ABSTRACT Introduction Immune-mediated TTP (iTTP) is a rare condition without pathognomonic signs and symptoms. For this reason, the diagnosis of iTTP may be delayed …
CH Lee, YC Huang, SS Li, YT Hsu, YP Chen… - Frontiers in …, 2022 - frontiersin.org
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder caused by severe ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats …
S Graciaa, S Adeagbo, G Fong, M Rollins… - Pediatric Blood & …, 2022 - Wiley Online Library
Background Thrombotic thrombocytopenic purpura (TTP) is a potentially life‐threatening disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and …
CL Karsenty, SE Kirk, HL Helber, JM Esquilin… - Frontiers in …, 2022 - frontiersin.org
Thrombotic thrombocytopenic purpura (TTP) is a rare but potentially life-threatening hematologic disease, presenting a myriad of diagnostic and management challenges in …
Thrombotic thrombocytopenic purpura (TTP) is an uncommon, but potentially disabling or even deadly, thrombotic microangiopathy with a well-studied mechanism of ADAMTS13 …
M Baysal, F Hindilerden, EG Ümit… - Turkish Journal of …, 2023 - ncbi.nlm.nih.gov
Objective: In recent years, new developments have been incorporated into daily practice in the management of immune thrombotic thrombocytopenic purpura (iTTP). In particular …
B Orhan, V Özkocaman, Ç Akdemir… - International Journal …, 2023 - Wiley Online Library
Introduction Thrombotic thrombocytopenic purpura (TTP) is a life‐threatening occlusive disease of the microcirculation characterized by systemic platelet plugs, organ ischemia …
M Baysal, F Hindilerden, EG Ümit, AM Demir… - 2023 - jag.journalagent.com
The median age of onset for iTTP is 40 years (8, 13). It has been reported that elderly iTTP patients may present with a higher frequency of renal and neurological manifestations and …